CryoPort Ships Stem Cells for Celprogen

LAKE FOREST, CA -- (MARKET WIRE) -- 12/20/07 -- CryoPort, Inc. (OTCBB: CYRX) today announced that it has completed a successful shipment of stem cells for Celprogen, Inc. from Southern California to Australia utilizing the CryoPort Express® Shipper.

Celprogen's CEO, Jay Sharma commented, "The CryoPort Express shipper has provided a more secure, cost-effective alternative to dry ice as we ship our stem cell research and therapeutic products to customers around the world. In addition to Australia, we have successfully utilized the CryoPort Express shipper for shipments to many diverse locations, such as South Africa, Japan, United Kingdom and Germany and have found the extra holding time an important hedge against delays that may result from regulatory and custom holds."

Peter Berry, CEO of CryoPort, stated, "We are pleased to be able to address the challenges that biotechnology companies such as Celprogen confront as they ship high value biomaterials in the global cold chain. These successful shipments reinforce the value of the CryoPort Express business model in both Europe and the developing world."

About CryoPort, Inc.

CryoPort (www.cryoport.com) develops leading edge, proprietary, technology-driven shipping and storage products for use in the rapidly growing global biotechnology and biopharmaceutical cold chain. The products developed by CryoPort are essential components of the infrastructure required for the testing, research and end user delivery of temperature-sensitive medicines and biomaterials in an increasingly complex logistical environment.

"SAFE HARBOR"

This press release contains forward-looking statements. The words "estimate," "possible" and "seeking" and similar expressions identify forward-looking statements, which speak only as to the date the statement was made. The company undertakes no obligation to publicly update or revise any forward-looking statements, whether because of new information, future events, or otherwise. Forward-looking statements are inherently subject to risks and uncertainties, some of which cannot be predicted, or quantified. Future events and actual results could differ materially from those set forth in, contemplated by, or underlying the forward-looking statements. The risks and uncertainties to which forward-looking statements are subject include, but are not limited to, the effect of government regulation, competition and other material risks.

Add to Digg Bookmark with del.icio.us Add to Newsvine

Contact:
Stuart Fine
Carpe DM, Inc.
908-469-1788

Released December 20, 2007